APOC1 Antikörper (AA 35-48) (FITC)
-
- Target Alle APOC1 Antikörper anzeigen
- APOC1 (Apolipoprotein C-I (APOC1))
-
Bindungsspezifität
- AA 35-48
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser APOC1 Antikörper ist konjugiert mit FITC
- Applikation
- Bitte anfragen
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Apolipoprotein C-I protein (35-48aa)
- Isotyp
- IgG
- Top Product
- Discover our top product APOC1 Primärantikörper
-
anti-Apolipoprotein C-I (APOC1) (AA 31-83) antibody
APOC1 Reaktivität: Human WB, ELISA, ICC, IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein C-I (APOC1) (AA 1-83) antibodyAPOC1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2E2-1A3 unconjugated
anti-Apolipoprotein C-I (APOC1) (AA 32-88) antibodyAPOC1 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein C-I (APOC1) (AA 32-88) antibodyAPOC1 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Maus Monoclonal unconjugated
anti-Apolipoprotein C-I (APOC1) (AA 35-48) antibodyAPOC1 Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein C-I (APOC1) antibodyAPOC1 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein C-I (APOC1) (AA 1-83) antibodyAPOC1 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Apolipoprotein C-I (APOC1) antibodyAPOC1 Reaktivität: Human, Ratte IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein C-I (APOC1) (AA 1-83) antibodyAPOC1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein C-I (APOC1) (Internal Region) antibodyAPOC1 Reaktivität: Human WB, ELISA, ICC, IF Wirt: Kaninchen Polyclonal unconjugated
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- APOC1 (Apolipoprotein C-I (APOC1))
- Andere Bezeichnung
- APOC1 (APOC1 Produkte)
- Synonyme
- Apo-CIB antikoerper, ApoC-IB antikoerper, ALPCI antikoerper, LRRG04 antikoerper, APOC1 antikoerper, apoc1 antikoerper, apolipoprotein C1 antikoerper, apolipoprotein C-I antikoerper, Apolipoprotein C-I antikoerper, APOC1 antikoerper, Apoc1 antikoerper, apoc1 antikoerper
- Hintergrund
-
Background: Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10 % of the protein of the VLDL and 2 % of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Binds free fatty acids and reduces their intracellular esterification. Modulates the interaction of APOE with beta-migrating VLDL and inhibits binding of beta-VLDL to the LDL receptor-related protein.
Aliases: Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I], APOC1
- UniProt
- P02654
- Pathways
- Apoptose
-
